The California Supreme Court recently denied the appeal of a transvaginal mesh manufacturer, C.R. Bard, who sought to annul a 2012 jury verdict awarding $5.5 million to the plaintiff in the transvaginal mesh lawsuit. Upon receiving the jury’s verdict, C.R. Bard declared that they planned to appeal the decision.
In a Bloomberg report from July 2012, a C.R. Bard representative named Scott Lowry stated that the “the complications suffered by the plaintiff…are not the fault” of C.R. Bard.
The plaintiff in the case, Christine Scott, received an implant of the C.R. Bard Avaulta Plus. Scott experienced mesh erosion, which in turn resulted in stress urinary incontinence (SUI) and pelvic pain, according to a Bloomberg report.
The Scott case was the first transvaginal mesh lawsuit to go to trial in the U.S., and thus, it is meaningful whether the case rests in favor of the plaintiff or defendant. C.R. Bard may be out of options for overturning the Scott verdict, and with increasing pressure to settle transvaginal mesh lawsuits, the mesh manufacturer may be moved to let the verdict rest.
Carey Danis & Lowe is a team of dedicated defective medical device lawyers who are currently filing transvaginal mesh lawsuits on behalf of women who sustained injuries from C.R. Bard implants, or implants manufactured by another company, such as Ethicon or Boston Scientific.
If you or someone you love has been injured by transvaginal mesh, we encourage you to use our offer of a free, no obligation case evaluation in order to better understand your case, legal options, and compensation eligibility.
Contact Carey Danis & Lowe today by phone at 800.721.2519, or complete a confidential personal injury claim form.References: Defective Medical Device litigation, Transvaginal Mesh